Assessment of the diagnostic accuracy of 18F-FDG PET/CT in prosthetic infective endocarditis and cardiac implantable electronic device infection: comparison of different interpretation criteria

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 43, Issue 13, 2016, Pages 2401-2412

  Jiménez Ballvé, Ana ^a   Pérez Castejón, María Jesús ^a   Delgado Bolton, Roberto C ^a,b   Sánchez Enrique, Cristina ^a   Vilacosta, Isidre ^a   Vivas, David ^a   Olmos, Carmen ^a   Ferrer, Manuel E Fuentes ^a   Carreras Delgado, José L ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITY OF LA RIOJA   (Spain)

Author keywords

Cardiac implantable electronic devices; Duke criteria; FDG; Infective endocarditis; PET CT; Prosthetic valve

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ATTENUATION CORRECTION; CARDIOVASCULAR DISEASE ASSESSMENT; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DUKE CRITERIA; FEMALE; GOLD STANDARD; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIVER; MALE; MECHANICAL HEART VALVE; PATHOLOGY; PROSTHETIC VALVE ENDOCARDITIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE; ADVERSE EFFECTS; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ELECTRODE IMPLANT; ENDOCARDITIS; HEART VALVE PROSTHESIS; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; PROSTHESIS-RELATED INFECTIONS; REPRODUCIBILITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; ELECTRODES, IMPLANTED; ENDOCARDITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84994298851     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-016-3463-9     Document Type: Article

References (24)

1. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363:139–49.
2. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis. 2008;50:274–81.
3. Uslan DZ, Sohail MR, Sauver JL, Friedman PA, Hayes DL, Stoner SM, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167:669–75.
4. Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, Sauver JL, et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J. 2008;155:896–903.
5. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–77.
6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler Jr VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.
7. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.
8. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.
9. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647–58.
10. Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep. 2014;16:459.
11. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–82.
12. Millar BC, Prendergast BD, Alavi A, Moore JE. 18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection. Int J Cardiol. 2013;167:1724–36.
13. Minamimoto R, Morooka M, Kubota K, Ito K, Masuda-Miyata Y, Mitsumoto T, et al. Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings. J Nucl Cardiol. 2011;18:516–20.
14. Langah R, Spicer K, Gebregziabher M, Gardon L. Effectiveness of prolonged fasting 18F-FDG PET/CT in the detection of cardiac sarcoidosis. J Nucl Cardiol. 2009;16:801–10.
15. Lum DP, Wandell S, Ko J, Coel MN. Reduction of myocardial-2-deoxy-2-(18F)fuoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. Mol Imaging Biol. 2002;4:332–7.
16. Kouijzer JE, Vos J, Janssen JR, van Dijk PJ, Oyen WJ, Bleeker-Rovers CP. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur J Nucl Med Mol Imaging. 2013;40:1102–7.
17. Ricciardi A, Sordillo P, Ceccarelli L, Maffongelli G, Calistri G, Di Pietro B, et al. 18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. Int J Infect Dis. 2014;28:219–24.
18. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616–25.
19. Cautela J, Alessandrini S, Cammilleri S, Giorgi R, Richet H, Casalta JP, et al. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study. Europace. 2013;15:252–7.
20. Graziosi M, Nanni C, Lorenzini M, Diemberger I, Bonfiglioli R, Pasquale F, et al. Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur J Nucl Med Mol Imaging. 2014;41:1617–23.
21. Kamel EM, Burger C, Burk A, Von Schulthess GK, Goerres GW. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol. 2003;13:724–8.
22. Goerres GW, Ziegler SI, Burger C, Berthold T, Von Schulthess GK, Buck A. Artefacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology. 2003;226:577–84.
23. Meignan M, Gallamini A, Haioun C. Report on the First International Workshop on Interim-PET-Scan in Lymphoma. 2009;50:1257–60.
24. Pilkington Woll JP, García Vicente AM, Talavera Rubio MP, Palomar Muñoz AM, Jiménez Londoño G, León Martín A, et al. Evaluación cuantitativa y cualitativa de la PET/TC a mitad del tratamiento en linfomas en la predicción de respuesta metabólica completa. Rev Esp Med Nucl Imagen Mol. 2013;32:70–6.